Mohammad Tobeiha, Negin Amin, Mohammad Esmaeil Shahaboddin, Mashallah Tabatabaizadeh, Sadegh Jafarnejad
{"title":"口服芝麻油对 2 型糖尿病患者人体测量指标、代谢指标和氧化应激指标的影响:双盲随机对照试验","authors":"Mohammad Tobeiha, Negin Amin, Mohammad Esmaeil Shahaboddin, Mashallah Tabatabaizadeh, Sadegh Jafarnejad","doi":"10.1007/s13410-024-01350-4","DOIUrl":null,"url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Background</h3><p>Sesame oil has several polyphenols with possible anti-diabetic and antioxidative characteristics. However, there is limited evidence for the efficacy of sesame oil on type 2 diabetes mellitus (T2DM) consequences. </p><h3 data-test=\"abstract-sub-heading\">Objective</h3><p>We aimed to investigate the effects of sesame oil as one of the safest edible oils and whether it could be an adjuvant therapy to medications in T2DM patients.</p><h3 data-test=\"abstract-sub-heading\">Methods </h3><p>Fifty-six patients with T2DM were enrolled in the study. They were randomly divided into two groups, receiving sesame oil (SO) as the intervention group (<i>n</i> = 28) or sunflower seeds oil (SSO) as the placebo group (<i>n</i> = 28) for 8 weeks. We assessed anthropometric, lipid profile, oxidative stress, and inflammatory indicators. We used paired sample <i>t</i>-test/Wilcoxon test and an unpaired <i>t</i>-test to examine the differences among and between the arms.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>The results showed that malondialdehyde (MDA) was reduced significantly in the SO group (1.33 ± 1.26, <i>p</i> = 0.001). However, the results in the SSO group were vice versa, and MDA noticeably increased in the control group after eight weeks (− 2.08 ± 1.01, <i>p</i> < 0.001). Despite the in-group changes, no significant differences were spotted in anthropometric, glycemia, lipid profile, and inflammatory indicators between both intervention and control groups.</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>Our findings suggest a possible antioxidative effect of sesame oil by decreasing MDA with no effects on other measured outcomes. This is a safe and effective option for relieving oxidative stress, as the supplementation with sesame oil for 8 weeks was not associated with harmful effects.</p>","PeriodicalId":50328,"journal":{"name":"International Journal of Diabetes in Developing Countries","volume":"161 1","pages":""},"PeriodicalIF":0.7000,"publicationDate":"2024-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The effect of oral consumption of sesame oil on anthropometric, metabolic and oxidative stress markers of patients with type 2 diabetes: a double-blind, randomized controlled trial\",\"authors\":\"Mohammad Tobeiha, Negin Amin, Mohammad Esmaeil Shahaboddin, Mashallah Tabatabaizadeh, Sadegh Jafarnejad\",\"doi\":\"10.1007/s13410-024-01350-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<h3 data-test=\\\"abstract-sub-heading\\\">Background</h3><p>Sesame oil has several polyphenols with possible anti-diabetic and antioxidative characteristics. However, there is limited evidence for the efficacy of sesame oil on type 2 diabetes mellitus (T2DM) consequences. </p><h3 data-test=\\\"abstract-sub-heading\\\">Objective</h3><p>We aimed to investigate the effects of sesame oil as one of the safest edible oils and whether it could be an adjuvant therapy to medications in T2DM patients.</p><h3 data-test=\\\"abstract-sub-heading\\\">Methods </h3><p>Fifty-six patients with T2DM were enrolled in the study. They were randomly divided into two groups, receiving sesame oil (SO) as the intervention group (<i>n</i> = 28) or sunflower seeds oil (SSO) as the placebo group (<i>n</i> = 28) for 8 weeks. We assessed anthropometric, lipid profile, oxidative stress, and inflammatory indicators. We used paired sample <i>t</i>-test/Wilcoxon test and an unpaired <i>t</i>-test to examine the differences among and between the arms.</p><h3 data-test=\\\"abstract-sub-heading\\\">Results</h3><p>The results showed that malondialdehyde (MDA) was reduced significantly in the SO group (1.33 ± 1.26, <i>p</i> = 0.001). However, the results in the SSO group were vice versa, and MDA noticeably increased in the control group after eight weeks (− 2.08 ± 1.01, <i>p</i> < 0.001). Despite the in-group changes, no significant differences were spotted in anthropometric, glycemia, lipid profile, and inflammatory indicators between both intervention and control groups.</p><h3 data-test=\\\"abstract-sub-heading\\\">Conclusion</h3><p>Our findings suggest a possible antioxidative effect of sesame oil by decreasing MDA with no effects on other measured outcomes. This is a safe and effective option for relieving oxidative stress, as the supplementation with sesame oil for 8 weeks was not associated with harmful effects.</p>\",\"PeriodicalId\":50328,\"journal\":{\"name\":\"International Journal of Diabetes in Developing Countries\",\"volume\":\"161 1\",\"pages\":\"\"},\"PeriodicalIF\":0.7000,\"publicationDate\":\"2024-05-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Diabetes in Developing Countries\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s13410-024-01350-4\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Diabetes in Developing Countries","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s13410-024-01350-4","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
The effect of oral consumption of sesame oil on anthropometric, metabolic and oxidative stress markers of patients with type 2 diabetes: a double-blind, randomized controlled trial
Background
Sesame oil has several polyphenols with possible anti-diabetic and antioxidative characteristics. However, there is limited evidence for the efficacy of sesame oil on type 2 diabetes mellitus (T2DM) consequences.
Objective
We aimed to investigate the effects of sesame oil as one of the safest edible oils and whether it could be an adjuvant therapy to medications in T2DM patients.
Methods
Fifty-six patients with T2DM were enrolled in the study. They were randomly divided into two groups, receiving sesame oil (SO) as the intervention group (n = 28) or sunflower seeds oil (SSO) as the placebo group (n = 28) for 8 weeks. We assessed anthropometric, lipid profile, oxidative stress, and inflammatory indicators. We used paired sample t-test/Wilcoxon test and an unpaired t-test to examine the differences among and between the arms.
Results
The results showed that malondialdehyde (MDA) was reduced significantly in the SO group (1.33 ± 1.26, p = 0.001). However, the results in the SSO group were vice versa, and MDA noticeably increased in the control group after eight weeks (− 2.08 ± 1.01, p < 0.001). Despite the in-group changes, no significant differences were spotted in anthropometric, glycemia, lipid profile, and inflammatory indicators between both intervention and control groups.
Conclusion
Our findings suggest a possible antioxidative effect of sesame oil by decreasing MDA with no effects on other measured outcomes. This is a safe and effective option for relieving oxidative stress, as the supplementation with sesame oil for 8 weeks was not associated with harmful effects.
期刊介绍:
International Journal of Diabetes in Developing Countries is the official journal of Research Society for the Study of Diabetes in India. This is a peer reviewed journal and targets a readership consisting of clinicians, research workers, paramedical personnel, nutritionists and health care personnel working in the field of diabetes. Original research articles focusing on clinical and patient care issues including newer therapies and technologies as well as basic science issues in this field are considered for publication in the journal. Systematic reviews of interest to the above group of readers are also accepted.